跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 151 条关于
“VHIR”
全部
151
临床试验
58
药物
26
机构
2
资讯
65
4个月前
UCB Acquires IMIDomics' Patient Insight Business to Advance Precision Medicine in Immune-Mediated Inflammatory Diseases
去年
Vir Biotechnology's Combination Therapy for Hepatitis Delta Receives FDA Fast Track Designation
2年前
Vir Biotechnology's HDV Therapy Receives FDA Breakthrough Therapy Designation
6个月前
Astellas and Vir Biotechnology Form $1.7 Billion Strategic Partnership for PSMA-Targeting T-Cell Engager VIR-5500 in Prostate Cancer
去年
Vir Biotechnology's SOLSTICE Trial of Soto-mutated Cancer Therapy Shows Promise
去年
Vir Biotechnology's Hepatitis Programs Show Promise, Justifying Buy Rating
去年
JPMorgan Raises Vir Biotechnology's Stock Target After Promising Tumor Cell Engager Data
去年
Vir Biotechnology's T-Cell Engagers Show Promise in Early Cancer Trials, Morgan Stanley Upgrades Stock
去年
Vir Biotechnology's Pipeline Shows Promise Amidst Cautious Optimism
2个月前
VHIO Renews Severo Ochoa Centre of Excellence Accreditation with Near-Perfect Score
第 1 页,共 7 页
上一页
下一页